#

Small caps

: 1091
In the month following the U.S. presidential election, Hertz stock has soared 55%. / Photo: REUTERS/Brendan McDermid
Small Caps·
WSJ notes biggest gainers in the small-cap S&P 600 since Trump victory
Inuvo CEO Richard Howe (pictured) says his company can revolutionize the advertising market, but clients’ fear of change stands in the way. Photo: linkedin.com/in/greg-johnson
Small Caps·
How small-cap Inuvo is rescuing the $200 billion advertising market amid cookie clampdown
Intuitive Machines focuses on lunar exploration. / Photo: Intuitive Machines
Small Caps·
Space exploration company Intuitive Machines slides after share offer with 26% discount
The payments segment was a key driver of IDT’s strong financial performance. / Photo: bossmoney.africa
Small Caps·
Fintech IDT Corporation gains on strong fiscal first-quarter financials
Nurexone is developing a drug to treat spinal cord injuries. / Photo: shutterstock
Small Caps·
Zacks SCR reiterates 400% upside call on Nurexone Biologic for risk-tolerant investors
The president-elect’s son, Donald Trump Jr. (center), has joined the board of PSQ Holdings. / Photo: x.com/MattEganCNN
Small Caps·
'Patriotic marketplace' PublicSquare jumps 270% after Trump son joins board
Archer aims to launch air taxi services in major cities worldwide. / Photo: archer.com
Small Caps·
Archer Aviation shares plunge following Stellantis CEO resignation
Miller Industries manufactures tow trucks and wreckers. / Photo: millerind.com
Small Caps·
Freedom Broker downgrades tow truck maker Miller Industries to 'hold'
Contango expects to produce 20% less ore from its Manh Choh project than initially planned. / Photo: Contango ORE
Small Caps·
Shares of gold miner Contango ORE plummet amid rising costs at Alaskan mine
One of the recommendations is Research Solutions, which supports companies in research-intensive industries. / Photo: researchsolutions.com
Small Caps·
Zacks spotlights five small caps with 'solid' short-term upside
The U.S. FDA has turned down Applied Therapeutics’ drug for a rare disease. / Photo: Unsplash/Louis Reed
Small Caps·
Applied Therapeutics plummets 76% after FDA declines to approve drug
MediciNova will see a capital infusion after Novartis infringed on patents with its drug Zolgensma. / Photo: Shutterstock
Small Caps·
Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute
Load more